In addition, the mutation SM5 and SM6 decreased the promoter activity most significantly (P < 0.01) and this region contains the core matrix of KLF6, indicating that KLF6 plays an important role in the regulation of TFPI-2 in breast cancer cells. This evidence concerns the gene KLF6 and breast cancer.